

Mastering Global Regulatory Pathways






Cross-Border Trial Management
Structured management of multi-continent Phase III trials across North America, Europe, and Asia-Pacific. Ensuring clinical rigour and data integrity at scale.
Phase II to III Acceleration
Proven record of accelerating critical Phase II to Phase III transitions while maintaining strict safety governance and regulatory compliance. Optimized pipeline progression.
Accelerated Regulatory Designations
Navigated complex rare disease and oncology regulatory pathways, securing accelerated FDA designations and EMA approvals. Bridging science with market access.
Structured Global Trial Oversight
Clinical Governance
Regulatory Alignment
Cross-Border Execution
Health Economics Integration
Implementing robust frameworks for clinical rigor and patient safety across all trial phases. Upholding ethical standards and data integrity.
Navigating cross-border FDA, EMA, and PMDA approval pathways with proactive strategy. Ensuring compliance and expedited market entry.
Directing multi-disciplinary teams for seamless trial execution across diverse global regions. Optimizing resource allocation and timelines.
Integrating early market-access strategy and health economics into clinical development. Maximizing long-term enterprise value.
Initiate a Confidential Dialogue
For retained executive searches and board appointments, connect directly. My dossier is available for review by qualified nomination committees.